Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03358888 · ClinicalTrials.gov registry record · NA
Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty
A NA study, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT03358888 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 228 participants.
The verdict
NCT03358888, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.
Interventions
- DRUG Standard of Care
- DRUG Multi-modal with as needed opioids
- DRUG Multi-modal with one week of opioids offered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2018-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03358888
The ClinicalTrials.gov registry entry for NCT03358888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rothman Institute Orthopaedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03358888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03358888 about?
NCT03358888 is a clinical study titled "Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty". This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients w...
What is the current status of trial NCT03358888?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2017-06-05. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT03358888?
The interventions under investigation include: Standard of Care (DRUG), Multi-modal with as needed opioids (DRUG), Multi-modal with one week of opioids offered (DRUG).
Who is sponsoring clinical trial NCT03358888?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.